Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 679
Last updated 2017-01-19
Summary
Through an online survey, participants will be shown different visual presentations of vaccination data related to schools and child care centers. Participants will rate how important this information is when thinking about their child's health and school choice. Participants will also be asked survey questions about their knowledge of Colorado state vaccination legislation, their opinions and practices related to childhood vaccinations, and their views of a Zika virus vaccine.
Conditions
- Healthy Children
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Sean O'Leary, MD, MPH · University of Colorado, Denver
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
4 Pillars Toolkit for Adolescent Vaccination
NCT02165722 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004799 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
NCT00258882 ·Status: COMPLETED
-
Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
NCT00258895 ·Status: COMPLETED ·Phase: PHASE3
-
Immunization Schedule Alert Platform
NCT03705455 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
NCT01661751 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
NCT06903221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
NCT00662870 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea
NCT01642589 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4